KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) FCF Margin (2016 - 2025)

Novavax has reported FCF Margin over the past 16 years, most recently at 26.63% for Q4 2025.

  • Quarterly results put FCF Margin at 26.63% for Q4 2025, up 18241.0% from a year ago — trailing twelve months through Dec 2025 was 23.09% (down 839.0% YoY), and the annual figure for FY2025 was 21.77%, down 707.0%.
  • FCF Margin for Q4 2025 was 26.63% at Novavax, down from 154.81% in the prior quarter.
  • Over the last five years, FCF Margin for NVAX hit a ceiling of 154.81% in Q3 2025 and a floor of 426.67% in Q1 2023.
  • Median FCF Margin over the past 5 years was 33.82% (2023), compared with a mean of 54.61%.
  • Peak annual rise in FCF Margin hit 83313bps in 2021, while the deepest fall reached -338672bps in 2021.
  • Novavax's FCF Margin stood at 158.75% in 2021, then surged by 81bps to 30.71% in 2022, then tumbled by -98bps to 60.76% in 2023, then tumbled by -244bps to 209.05% in 2024, then surged by 87bps to 26.63% in 2025.
  • The last three reported values for FCF Margin were 26.63% (Q4 2025), 154.81% (Q3 2025), and 73.0% (Q2 2025) per Business Quant data.